SCHEMBL24711679

SCHEMBL24711679

Cc1cccc(/C(C=N)=C/N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ACHE P22303 2/20 0.39
▸ HTR3E A5X5Y0 1/20 0.39
▸ HTR3B O95264 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ HTR3D Q70Z44 1/20 0.39
▸ HTR3C Q8WXA8 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ KCNK3 O14649 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ KCNK9 Q9NPC2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ NT5E P21589 1/20 0.38
▸ FAAH O00519 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23260541 0.85 PARP1 (0.47) PARP1HDAC8HDAC6SMN1; SMN2ACHE
SCHEMBL17034487 0.79 PARP1 (0.42) PARP1HDAC8HDAC6SMN1; SMN2ACHE
SCHEMBL20037381 0.79 HDAC8 (0.43) PARP1HDAC8HDAC6SMN1; SMN2ACHE
SCHEMBL18962611 0.78 PARP1 (0.48) PARP1SMN1; SMN2HTR3EHTR3BHTR3A
SCHEMBL18962686 0.78 PARP1 (0.48) PARP1HDAC6SMN1; SMN2KCNK3MEN1
SCHEMBL17468521 0.77 PARP1 (0.41) PARP1HDAC8HDAC6SMN1; SMN2ACHE
SCHEMBL25721432 0.77 PRSS1 (0.57) PARP1SMN1; SMN2HTR3EHTR3BHTR3A
SCHEMBL14538523 0.76 ALDH1A1 (0.40) HDAC6SMN1; SMN2ACHEHTR3EHTR3B
SCHEMBL19250178 0.76 PARP1 (0.43) PARP1HDAC8HDAC6SMN1; SMN2KCNK3
SCHEMBL15850351 0.76 F2 (0.42) PARP1KMT2ATDP1POLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3720858-B1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARM INC (US) 2023-06-07 — — EP disclosed
WO-2022261069-A1 METHODS AND TREATMENT OF VIRAL INFECTION WITH SUBSTITUTED PYRAZOLO-PYRIMIDINES Verge Analytics, Inc. (US) 2022-12-15 — — WO disclosed
Send feedback